Open AccessHow Optimal is the Medical Management of Patients Prior to Major Reconstructive Vascular Surgery? The Results of a Cross-sectional Study
Author(s) -
C. Marshall,
Peter H. Lin,
Thi Thanh Tam Huynh,
Panagiotis Kougias
Publication year - 2009
Publication title -
vascular and endovascular surgery/vascular and endovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.46
H-Index - 45
eISSN - 1938-9116
pISSN - 1538-5744
DOI - 10.1177/1538574408330399
Subject(s) - medicine , cross sectional study , vascular surgery , surgery , reconstructive surgery , general surgery , cardiac surgery , pathology
Risk factor modification is important in patients with vascular disease. Guidelines suggest that this patient population benefits from a medical regimen of antiplatelets, statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom